Caldor Health Technologies - About the company
Caldor Health Technologies is a seed company based in Coimbatore (India), founded in 2022 by Thilak Chakaravarthi and Harisharan Ramesh. It operates as a Developer of medical devices within the ENT healthcare segment. Caldor Health Technologies has raised $278K in funding from Centre for Incubation and Business Acceleration and AIC-CCMB, with a current valuation of ₹*****. The company has 19 active competitors, including 5 funded and 2 that have exited. Its top competitors include companies like NeuroMark Genomics, Spirox and Navage.
Company Details
Developer of medical devices within the ENT healthcare segment. The company specializes in the development of medical devices, diagnostics, and digital tools specifically tailored for addressing nasal-related diseases within the ENT healthcare segment.
- Website
- caldorhealthtech.com
- Registered Address
- No 12 Rose Garden Thondamuthur Main Road, Kurumbapalayam Vedapatti Post, Vedapatti, Coimbatore, Coimbatore South, Tamil Nadu, India, 641007
Key Metrics
Founded Year
2022
Location
Coimbatore, India
Stage
Seed
Total Funding
$278K in 4 rounds
Latest Funding Round
Post Money Valuation
₹***** as on May 21, 2026
Ranked
7th among 19 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
6 as on Jun 30, 2026
Similar Companies
Legal entities associated with Caldor Health Technologies
Caldor Health Technologies is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CALDOR HEALTH TECHNOLOGIES PRIVATE LIMITED CIN: U33110TZ2022PTC040402 , India, Active | Dec 02, 2022 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download Caldor Health Technologies' company profile
Caldor Health Technologies's funding and investors
Caldor Health Technologies has raised a total funding of $278K over 4 rounds. Its first funding round was on Mar 24, 2023. Caldor Health Technologies has 2 institutional investors.
Here is the list of recent funding rounds of Caldor Health Technologies:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 21, 2026 | 5167979 | Seed | 5032175 | 4897035 | 7585305 | 1228444 |
Nov 20, 2025 | 5355752 | Seed | 4024349 | 6025531 | 9697780 | 9904009 |
Nov 01, 2024 | 6665047 | Seed | 9783154 | 6842049 |
View details of Caldor Health Technologies's funding rounds and investors
Caldor Health Technologies' founders and board of directors
Founder? Claim ProfileThe founders of Caldor Health Technologies are Thilak Chakaravarthi and Harisharan Ramesh. Thilak Chakaravarthi is the CEO of Caldor Health Technologies.
Here are the details of Caldor Health Technologies' key team members:
- Thilak Chakaravarthi: Co-Founder & CEO of Caldor Health Technologies. Contact Info: 1 email address and 1 phone number
- Harisharan Ramesh: Co-Founder & CTO of Caldor Health Technologies. Contact Info: 1 email address and 1 phone number
View details of Caldor Health Technologies's Founder profiles and Board Members
Caldor Health Technologies' employee count trend
Caldor Health Technologies has 6 employees as of Jun 26. Here is Caldor Health Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Caldor Health Technologies's Competitors and alternates
Top competitors of Caldor Health Technologies include NeuroMark Genomics, Spirox and Navage. Here is the list of Top 10 competitors of Caldor Health Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NeuroMark Genomics 2018, Boulder (United States), Series C | Developer of a system for chronic rhinitis treatment via radiofrequency. | $110M | 49/100 | |
2nd | Spirox 2013, Menlo Park (United States), Acquired | Provider of non-invasive treatment of nasal valve obstruction | $69.7M | 42/100 | |
3rd | Navage 2007, Broadview Heights (United States), Series A | Nasal care products for congestion relief and improved breathing | $19.1M | 40/100 | |
4th | NeilMed 2000, Santa Rosa (United States), Unfunded | Nasal and sinus care products for a clean nose feeling | - | - | 39/100 |
5th | Developer of a medical device for the treatment of migraine | - | - | 34/100 | |
6th | Summit Medical 2010, Saint Paul Park (United States), Acquired | Medical device manufacturer providing innovative solutions for healthcare professionals to improve patient outcomes | - | - | 33/100 |
7th | Caldor Health Technologies 2022, Coimbatore (India), Seed | Developer of medical devices within the ENT healthcare segment | $278K | 36/100 | |
8th | Spirair 2020, United States, Series B | Developer of medical devices to treat nasal septal deviation | $24.7M | 31/100 | |
9th | Provider of an artificial nose sensor for on-site bacterial tests | - | - | 30/100 | |
10th | Breathe Right 1982, Mondovi (United States), Unfunded | Nasal congestion relief with Breathe Right strips for better breathing | - | - | 24/100 |
Looking for more details on Caldor Health Technologies's competitors? Click here to see the top ones
Caldor Health Technologies's Investments and acquisitions
Caldor Health Technologies has made no investments or acquisitions yet.
Reports related to Caldor Health Technologies
Here is the latest report on Caldor Health Technologies's geography:
Are you a Founder ?
FAQs about Caldor Health Technologies
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company
